Safer non-cardiac surgery for patients with coronary artery disease

M. Avidan,B. Hunt
DOI: https://doi.org/10.1136/BMJ.319.7205.320
1998-11-21
British Medical Journal
Abstract:Editor—In Sonksen et al’s editorial on safer non-cardiac surgery for patients with coronary artery disease the authors say that they considered that aspirin does not increase perioperative bleeding.1 We were astonished to read this. They based the statement on studies of aspirin’s mechanism of action in vitro and the preoperative use of the bleeding time. The bleeding time correlates poorly with other tests of platelet function and is a poor predictor of bleeding.2 The editorial states that aspirin has no effect on platelet aggregation induced by thrombin and high dose collagen. This statement is based only on a study that used flow cytometry. In other studies, laboratory tests of platelet function have shown impaired platelet activity induced by collagen and thrombin after aspirin.3,4 Impaired platelet function in vitro has been documented for more than 72 hours after ingestion of aspirin. In vitro studies are not predictive of in vivo behaviour, and several clinical studies have clearly shown that aspirin does increase bleeding in both cardiac and non-cardiac surgery.3,5 For prostate surgery the withdrawal of aspirin for at least a week preoperatively has been suggested.5 For certain types of surgery, such as neurosurgery, eye surgery, and spinal cord surgery, increased bleeding may have devastating consequences. It is thus inappropriate to suggest that all patients with ischaemic heart disease should receive aspirin in the perioperative period. Aspirin may well have a role in certain patients with ischaemic heart disease undergoing non-cardiac surgery. Before specific recommendations can be made, however, clinical trials should be done to determine the risks and benefits of this intervention in various settings. In particular, the benefit of preoperative aspirin has to be balanced against the risk of increasing postoperative blood loss, re-exploration for excessive bleeding, and transfusion requirements.3
What problem does this paper attempt to address?